Detail Project Report
Detail Project Report
of
M/s. Kaniwa Biosceince
Pvt. Ltd.
M/s. Kaniwa Biosceince Pvt. Ltd.
Capacity Product
Year Utili.
Total
2024-25 30% 196560000 1965.60
2025-26 30% 196560000 1965.60
2026-27 35% 229320000 2293.20
2027-28 40% 262080000 2620.80
2028-29 45% 294840000 2948.40
2029-30 50% 327600000 3276.00
2030-31 55% 360360000 3603.60
Rs. In Lac
Land 0.00
Proposed Building 0.00 Term Loan From Bank. 885.60
Existing Building 0.00 Capital 320.00
Existing Machinery 0.00 Unsecured Loan 466.10
New Machinery & Electrification 1376.09 Cash Credit From Bank 110.00
Other Cost 223.61
BG Margin 0.00
Deposit & Other Exp. 25.00
Elecrification 0.00
Pre Operative Expense 7.00
Margin For Working capital 150.00
Total 1781.70 Total 1781.70
Loan Requirement
Margin Margin % Loan
Item Cost Amt
Land 0.00 0.00 100.00% 0.00
Proposed Building 0.00 0.00 100.00% 0.00
Existing Building 0.00 0.00 100.00% 0.00
Existing Machinery 0.00 0.00 100.00% 0.00
New Machinery & Electrification 1376.09 490.49 35.64% 885.60
Other Cost 223.61 223.61 100.00% 0.00
BG Margin 0.00 0.00 100.00% 0.00
Deposit & Other Exp. 25.00 25.00 100.00% 0.00
Elecrification 0.00 0.00 100.00% 0.00
Pre Operative Expense 7.00 7.00 100.00% 0.00
Margin For Working capital 150.00 40.00 26.67% 110.00
Total 1781.70 786.10 995.60
Production Capacity
Sr No Product Product
1 Iicence capacity 17.1 Ton
2 Install capacity 14 Ton
3 Capacity Per Month (In "MT") 14 Ton
4 Production for the year (In "MT") 168 Ton
5 Rate per MT ( Rs.) 3900000 Per MT
6 Total production in Rupee 655200000
6552.00
M/s. Kaniwa Biosceince Pvt. Ltd.
A. RAW MATERIAL
Consumption in Materail Production in Total cost in
Sr.No Name of Material friest year Required in % first year( in first year
I RAW MATERIAL 127764000 65.00% 196560000 127764000
Rs. In Lac
Years Capacity utilisation Raw material
2025 30% 1277.64
2026 30% 1277.64
2027 35% 1535.58
2028 40% 1796.95
2029 45% 2047.57
2030 50% 2302.07
2031 55% 2553.28
Total 7935.38
Power
Expected wages during first year at capacity utilisation 25% will be as under
Rate per
month per Total pay per Total pay
Sr.NO Category No employee month per year
I Manager 1 35000 35000 420000
II Operator 3 25000 75000 900000
III Helper 3 15000 45000 540000
IV Labour 17 12000 204000 2448000
V Office staff 6 18000 108000 1296000
Total 30 105000 467000 5604000
It has been assumed that the worker will get increament @ 15% every year. So wages
during the subsquent year at various level of capacity utilisation will be as under
Capacity
Year Utilisation Repairing cost in Rs
2025 30% 24.00
2026 30% 24.00
2027 35% 27.99
2028 40% 31.99
2029 45% 35.99
2030 50% 39.99
2031 55% 43.99
Depreciation:
Depreciation
Year ( In Rs. )
2025 101.31
2026 101.31
2027 101.31
2028 101.31
2029 101.31
2030 101.31
2031 101.31
INTEREST
Year 2022-23 2023-24 2024-25 2025-26 2026-27 2027-28 2028-29 2029-30 2030-31
Yly Int 0.00 60.02 83.40 70.44 56.70 42.95 29.21 15.46 2.67
Yly Instal 0.00 0.00 94.46 141.70 141.70 141.70 141.70 141.70 82.66
Pri O/s. 449.85 885.60 791.13 649.44 507.74 366.04 224.35 82.65 0.00
M/s. Kaniwa Biosceince Pvt. Ltd.
SALE VALUE & SALES REALISATION
Sr. 2021-22 2022-23 2023-24 2024-25 2025-26 2026-27 2027-28 2028-29 2029-30 2030-31
No Particulars Audited Audited Actual Proj. Proj. Proj. Proj. Proj. Proj. Proj.
1 Export Sale 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
2 Domestic Sale 0.00 0.00 0.00 491.40 1965.60 2293.20 2620.80 2948.40 3276.00 3603.60
Add:GST 0.00 0.00 0.00 88.45 353.81 412.78 471.74 530.71 589.68 648.65
Gross Sale 0.00 0.00 0.00 579.85 2319.41 2705.98 3092.54 3479.11 3865.68 4252.25
Less GST 0.00 0.00 0.00 88.45 353.81 412.78 471.74 530.71 589.68 648.65
3 Net Sales 0.00 0.00 0.00 491.40 1965.60 2293.20 2620.80 2948.40 3276.00 3603.60
Sr. 2021-22 2022-23 2023-24 2024-25 2025-26 2026-27 2027-28 2028-29 2029-30 2030-31
No Particulars Audited Audited Actual Proj. Proj. Proj. Proj. Proj. Proj. Proj.
11 (i) Add other non-operating income
(a) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
(b)
Sub-Total (income) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
(ii) Deduct other non operating expense
(a) Interest to Partner's 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
(b) Director Remunaration 0.00 0.00 0.00 0.00 10.00 16.00 28.00 36.00 38.00 42.00
Sub-Total (expenses) 0.00 0.00 0.00 0.00 10.00 16.00 28.00 36.00 38.00 42.00
(iii) Net of other non operating
ome/expenses 0.00 0.00 0.00 0.00 -10.00 -16.00 -28.00 -36.00 -38.00 -42.00
12 Profit before tax/loss 0.00 0.00 0.00 21.15 124.37 146.51 169.61 192.77 215.44 238.05
13 Provision for tax 0.00 0.00 0.00 3.17 18.66 21.98 25.44 28.92 32.32 35.71
14 NET PROFIT/LOSS 0.00 0.00 0.00 17.98 105.71 124.53 144.17 163.85 183.12 202.35
(A) Equity dividend paid/Drawing 0.00 0.00 0.00 0.00 15.86 31.13 50.46 73.73 100.72 131.52
(B) Dividend rate 0.00% 0.00% 0.00% 0.00% 15.00% 25.00% 35.00% 45.00% 55.00% 65.00%
16 RETAINED PROFIT 0.00 0.00 0.00 17.98 89.86 93.40 93.71 90.12 82.41 70.82
17 Retained profit to net profit (% age) 0.00 0.00 No profit 100.00 85.00 75.00 65.00 55.00 45.00 35.00
Sr. LIABILITIES 2021-22 2022-23 2023-24 2024-25 2025-26 2026-27 2027-28 2028-29 2029-30 2030-31
No Audited Audited Actual Proj. Proj. Proj. Proj. Proj. Proj. Proj.
CURRENT LIABILITIES
Short term liabilities
1 (i) applicant bank from 0.00 0.00 0.00 110.00 110.00 110.00 110.00 110.00 110.00 110.00
(ii) from other bank
(iii) of which BP/BD
SUB-TOTAL (A) 0.00 0.00 0.00 110.00 110.00 110.00 110.00 110.00 110.00 110.00
2 Short term borrowing from other
3 Sundry creditor (Trade) 0.00 0.00 0.00 86.51 80.52 96.44 112.79 128.43 144.34 160.04
Creditor for Capital
4 Goods/Expense 0.24 0.71 27.10 0.00 0.00 0.00 0.00 0.00 0.00 0.00
5 Provision for taxation 0.00 0.00 0.00 3.17 18.66 21.98 25.44 28.92 32.32 35.71
6 Dividend payable
7 Other statutory liabilities 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
23 Surplus/deficit in profit & loss account 0.00 0.00 -3.39 14.59 104.44 197.85 291.55 381.67 464.08 534.90
24 NET WORTH 79.34 181.25 316.61 434.59 524.44 617.85 711.55 801.67 884.08 954.90
25 TOTAL LIABILITIES 275.31 868.57 1682.81 1915.75 1873.91 1845.36 1817.68 1785.72 1746.25 1753.75
M/s. Kaniwa Biosceince Pvt. Ltd.
PROJECTED BALANCE-SHEET
Sr. 2021-22 2022-23 2023-24 2024-25 2025-26 2026-27 2027-28 2028-29 2029-30 2030-31
No ASSETS Audited Audited Actual Proj. Proj. Proj. Proj. Proj. Proj. Proj.
CURRENT ASSETS
26 Cash and bank balance 8.51 21.47 3.31 3.60 4.98 5.33 7.85 9.68 10.42 11.06
Investment(other than long term)
27 (i)Government & othe trustee
(ii)Fixed deposit with bank
FIXED ASSETS
35 GROSS BLOCK 0.65 62.03 1133.59 1599.70 1599.70 1599.70 1599.70 1599.70 1599.70 1599.70
36 Depreciation to date 0.00 0.00 0.00 25.33 126.63 227.94 329.25 430.55 531.86 633.17
37 NET BLOCK 0.65 62.03 1133.59 1574.38 1473.07 1371.76 1270.45 1169.15 1067.84 966.53
OTHER NON CURRENT ASSETS
Investment/bookdebt/advances/deposit
which are not current asset
38 i) a) Investment in subsidiary Co./affilates
b) Fixed Deposit 0.00 38.05 40.20 40.72 40.72 40.72 40.72 40.72 40.72 40.72
ii) Advances to supplier of capital goods
PROJECTED BALANCE-SHEET
Sr. 2021-22 2022-23 2023-24 2024-25 2025-26 2026-27 2027-28 2028-29 2029-30 2030-31
No ASSETS Audited Audited Actual Proj. Proj. Proj. Proj. Proj. Proj. Proj.
39 Non consumable store & spare
Other non current assets
40 incld.due from director
41 TOTAL NON CURRENT ASSETS 0.00 38.05 40.20 40.72 40.72 40.72 40.72 40.72 40.72 40.72
ASSETS SIDE IS MORE BY 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
LIABILITY SIDE IS MORE BY 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
M/s. Kaniwa Biosceince Pvt. Ltd.
COMPARATIVE STATEMENT OF
CURRENT ASSETS AND CURRENT LIABILITIES
Sr. 2021-22 2022-23 2023-24 2024-25 2025-26 2026-27 2027-28 2028-29 2029-30 2030-31
No CURRENT ASSETS Audited Audited Actual Proj. Proj. Proj. Proj. Proj. Proj. Proj.
1 Raw material
a) Imported 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
( months' consumption) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
b) Indigenous 0.00 0.00 0.00 26.62 37.26 44.79 52.41 59.72 67.14 74.47
( months' consumption) 0.00 0.00 0.00 0.25 0.35 0.35 0.35 0.35 0.35 0.35
Sr. 2021-22 2022-23 2023-24 2024-25 2025-26 2026-27 2027-28 2028-29 2029-30 2030-31
No Particulars Audited Audited Actual Proj. Proj. Proj. Proj. Proj. Proj. Proj.
1 SOURCES
a Net profit(after tax) 0.00 0.00 0.00 17.98 105.71 124.53 144.17 163.85 183.12 202.35
b Depreciation 0.00 0.00 0.00 25.33 101.31 101.31 101.31 101.31 101.31 101.31
c Increase in capital 79.34 101.91 135.36 100.00 0.00 0.00 0.00 0.00 0.00 0.00
d Increase in Term liabilities(incld.deposit)
195.73 490.47 652.65 0.00 0.00 0.00 0.00 0.00 0.00 0.00
e Decrease in fixed assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
f Decrease in other non-current/Integ. assets
0.00 0.00 -2.15 -0.52 0.00 0.00 0.00 0.00 0.00 0.00
g Total 275.07 592.38 785.86 142.78 207.02 225.84 245.47 265.16 284.43 303.66
2 USES
a Net loss 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
b Decrease in term loan(incld.deposit) 0.00 0.00 0.00 201.56 141.70 141.70 141.70 141.70 82.66 0.00
c Increase in fixed assets 0.65 61.38 1071.56 466.11 0.00 0.00 0.00 0.00 0.00 0.00
d Increase in other non-current assets 0.00 38.05 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
e Dividend payment/Drawing 0.00 0.00 0.00 0.00 15.86 31.13 50.46 73.73 100.72 131.52
f Other
g Total 0.65 99.43 1071.56 667.68 157.55 172.83 192.15 215.43 183.37 131.52
3 Long term surplus/deficit 274.42 492.95 -285.70 -524.89 49.47 53.01 53.32 49.73 101.06 172.13
4 Increase/decrease in current assets274.66 493.83 -259.47 -208.36 59.46 72.76 73.63 69.35 61.83 108.81
5 Increase/decrease in other current liability
0.24 0.88 26.23 206.53 9.99 19.75 20.31 19.62 -39.23 -63.32
6 Increase/decrease in working capital gap
274.42 492.95 -285.70 -414.89 49.47 53.01 53.32 49.73 101.06 172.13
7 Net surplus/deficit (difference of 3-6) 0.00 0.00 0.00 -110.00 0.00 0.00 0.00 0.00 0.00 0.00
8 Increase/decrease in bank borrowing 0.00 0.00 0.00 110.00 0.00 0.00 0.00 0.00 0.00 0.00
BREAK-UP OF (4)
a Increase/decrease in raw-material 0.00 0.00 0.00 26.62 10.65 7.52 7.62 7.31 7.42 7.33
b Increase/decrease in stock-in-process0.00 0.00 0.00 20.00 1.00 1.05 1.10 1.16 1.22 1.28
c Increase/decrease in finished goods 0.00 0.00 0.00 40.00 2.00 2.10 2.21 2.32 2.43 5.11
d Increase/decrease in receivable-Domestic0.00 0.00 0.00 193.28 0.00 54.76 56.05 49.61 48.97 93.42
e Increase/decrease in receivable-Export 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
f Increase/decrease in store-spare 0.00 0.00 0.00 0.98 2.95 0.66 0.66 0.66 0.66 0.66
g Increase/decrease in other current 274.66
assets 493.83 -259.47 -489.25 42.87 6.67 5.99 8.30 1.14 1.03
Total 274.66 493.83 -259.47 -208.36 59.46 72.76 73.63 69.35 61.83 108.81
M/s. Kaniwa Biosceince Pvt. Ltd.
Sr. 2021-22 2022-23 2023-24 2024-25 2025-26 2026-27 2027-28 2028-29 2029-30 2030-31
No Particulars Audited Audited Actual Proj. Proj. Proj. Proj. Proj. Proj. Proj.
1 Depreciation 0.00 0.00 0.00 25.33 101.31 101.31 101.31 101.31 101.31 101.31
2 Net profit(after tax)/Tax Paid 0.00 0.00 0.00 17.98 105.71 124.53 144.17 163.85 183.12 202.35
3 Cash accrual 0.00 0.00 0.00 43.30 207.02 225.84 245.47 265.16 284.43 303.65
ADD OTHER SOURCE OF FUND
4 Increase in equity 79.34 101.91 135.36 100.00 0.00 0.00 0.00 0.00 0.00 0.00
5 Increase in term loan/debenture 0.00 449.85 443.08 0.00 0.00 0.00 0.00 0.00 0.00 0.00
6 Increase in unsecured deposit 195.73 40.62 209.57 41.93 0.00 0.00 0.00 0.00 0.00 0.00
7 Increase in deferred liabilities 0.00 0.00 443.08 0.00 0.00 0.00 0.00 0.00 0.00 0.00
8 Increase in bank borrowing 0.00 0.00 0.00 110.00 0.00 0.00 0.00 0.00 0.00 0.00
9 Increase in other current liability 0.24 0.88 26.23 206.53 9.99 19.75 20.31 19.62 0.00 0.00
10 Decrease in inventory 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
11 Decrease in book debt 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
12 Decrease in other current assets 0.00 0.00 241.31 489.54 0.00 0.00 0.00 0.00 0.00 0.00
13 Decrease in Non-current assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
14 Decrease in fixed assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
15 Increase in other 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
16 Decrease in other 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
17 TOTAL FUND AVAILABLE 275.31 593.26 1498.63 991.30 217.02 245.59 265.78 284.78 284.43 303.66
M/s. Kaniwa Biosceince Pvt. Ltd.
Rs. In Lac
Sr. 2021-22 2022-23 2023-24 2024-25 2025-26 2026-27 2027-28 2028-29 2029-30 2030-31
No Particulars Audited Audited Actual Proj. Proj. Proj. Proj. Proj. Proj. Proj.
DEDUCT
18 Decrease in equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
19 Decrease in term loan/debenture 0.00 0.00 0.00 243.49 141.70 141.70 141.70 141.70 82.66 0.00
20 Decrease in deferred liabilities 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
21 Decrease in unsecured deposit 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
22 Decrease in bank borrowing 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
23 Decrease in other current liabilities 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 39.23 63.32
24 Increase in inventory 0.00 0.00 0.00 87.60 16.60 11.33 11.59 11.44 11.72 14.36
25 Increase in book debt 0.00 0.00 0.00 193.28 0.00 54.76 56.05 49.61 48.97 93.42
26 Increase in other current assets 266.15 480.87 0.00 0.00 41.48 6.32 3.46 6.47 0.40 0.39
27 Increase in fixed assets 0.65 61.38 1071.56 466.11 0.00 0.00 0.00 0.00 0.00 0.00
28 Increase in Non-current assets 0.00 38.05 2.15 0.52 0.00 0.00 0.00 0.00 0.00 0.00
29 Dividend/Drawing 0.00 0.00 0.00 0.00 15.86 31.13 50.46 73.73 100.72 131.52
30 Any other 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
31 TOTAL OUTLAY 266.80 580.30 1073.71 991.01 215.63 245.24 263.26 282.95 283.69 303.02
Balance surplus/shortfall 8.51 12.96 424.92 0.29 1.38 0.35 2.52 1.83 0.74 0.64
Opening cash balance 0.00 8.51 21.47 3.31 3.60 4.98 5.33 7.85 9.68 10.42
Closing cash balance 8.51 21.47 446.39 3.60 4.98 5.33 7.85 9.68 10.42 11.06
M/s. Kaniwa Biosceince Pvt. Ltd.
Sr No Particulars 2021-22 2022-23 2023-24 2024-25 2025-26 2026-27 2027-28 2028-29 2029-30 2030-31
Audited Audited Actual Proj. Proj. Proj. Proj. Proj. Proj. Proj.
1 Equity 79.34 181.25 320.00 320.00 320.00 320.00 320.00 320.00 320.00 320.00
2 Preference
Tangible NetShare
Worth (Excl .rev 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
3 .reserve & Net of intangible
Assests) 0.00 0.00 -3.39 14.59 104.44 197.85 291.55 381.67 464.08 534.90
Investment in cos. of which 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
4 associated companies
/subsidiaries
5 Adjusted TNW 79.34 181.25 316.61 434.59 524.44 617.85 711.55 801.67 884.08 954.90
6 Capital Employed *(total 275.07 867.45 1655.46 1571.87 1520.03 1471.74 1423.75 1372.18 1371.93 1442.75
7 Funds employed)
Net Block 0.65 62.03 1133.59 1574.38 1473.07 3072.87 1270.45 1169.15 1067.84 966.53
8
Net Sales:Domestic 0.00 0.00 0.00 491.40 1965.60 2293.20 2620.80 2948.40 3276.00 3603.60
9 Export 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total 0.00 0.00 0.00 491.40 1965.60 2293.20 2620.80 2948.40 3276.00 3603.60
10 Other Income 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
11 Depriciation 0.00 0.00 0.00 25.33 101.31 101.31 101.31 101.31 101.31 101.31
12 Gross Profit before tax 0.00 0.00 0.00 21.15 124.37 146.51 169.61 192.77 215.44 238.05
13 Net Profit/loss 0.00 0.00 0.00 17.98 105.71 124.53 144.17 163.85 183.12 202.35
14 Cash Accruals ( i+k ) 0.00 0.00 0.00 43.30 207.02 225.84 245.47 265.16 284.43 303.65
15 Net Profit/Capital Employed(%) 0.00 0.00 0.00% 1.14% 6.95% 8.46% 10.13% 11.94% 13.35% 14.02%
16 Current Assests 274.66 768.49 509.02 300.66 360.12 432.88 506.50 575.85 637.68 746.50
17 Current Liabilities 0.24 1.12 27.35 343.88 353.87 373.62 393.93 413.54 374.32 311.00
RATIO
18 Current Ratio 1144.42 686.15 18.61 0.87 1.02 1.16 1.29 1.39 1.70 2.40
19 CURRENT RATIO (EXCLI. INST) 1144.42 686.15 18.61 1.49 1.70 1.87 2.01 2.12 2.19 2.40
20 Assets Turnover ratio 0.00 0.00 0.00 0.26 1.05 1.24 1.44 1.65 1.88 2.05
21 Total Term Liab./TNW 2.47 3.79 4.23 2.62 1.90 1.38 1.00 0.71 0.55 0.51
Total Outside Liab./TNW 2.47 3.79 4.32 3.41 2.57 1.99 1.55 1.23 0.98 0.84
22 Profitability %:PAN/Net Sales 0.00 0.00% #DIV/0! 3.66% 5.38% 5.43% 5.50% 5.56% 5.59% 5.62%
23 DSCR a)Company as a whole 0.00 0.00 0.00 0.71 1.31 1.42 1.56 1.72 1.91 3.59
24 Inventory+Receivable/Sales 0.00 0.00 #DIV/0! 0.53 0.14 0.15 0.16 0.16 0.16 0.18
25 tax 0.00 0.00 0.00 3.17 18.66 21.98 25.44 28.92 32.32 35.71
Depreciation as per Companies Act
Useful
Rate Method Life 2024-25 2025-26 2026-27 2027-28 2028-29 2029-30 2030-31
Gross Net Net Net Net Net Net Net
Plant & Machinery Block Dep Block Dep Block Dep Block Dep Block Dep Block Dep Block Dep Block
Plant & Machinery 6.33% SLM 15 1376.09 87.15 1201.79 87.15 1114.63 87.15 1027.48 87.15 940.33 87.15 853.18 87.15 766.02 87.15 678.87
Other machinery 6.33% 15 223.61 14.15 195.30 14.15 181.15 14.15 166.99 14.15 152.84 14.15 138.68 14.15 124.53 14.15 110.37
Total 1599.70 101.31 1397.09 101.31 1295.78 101.31 1194.47 101.31 1093.17 101.31 991.86 101.31 890.55 101.31 789.25